Dailypharm Live Search Close

Joint development & production of DM Combi with SK Chem & AZ

By Kim, Jin-Gu | translator Eo, Yun-Ho

23.06.19 08:55:28

°¡³ª´Ù¶ó 0
Holding the first commercial product production celebration

AZ will apply for a domestic permit

 ¡ãFrom left, Kim Yun-ho, CEO of Pharma Business, SK Chemicals CEO Ahn Jae-hyun, SK Discovery Vice Chairman Choi Chang-won, AstraZeneca International Market China Senior Vice Chairman Leon Wang, AstraZeneca Asia Regional President Sylvia Varela, AstraZeneca International Market Financial Director Ankush Nandra Vice Chairman, Kim Sang-pyo, President and CEO of AstraZeneca Koreaµð½ºÄ¿¹ö¸® ÃÖâ¿ø ºÎȸÀå, ¾Æ½ºÆ®¶óÁ¦³×Ä« ÀÎÅͳ»¼Å³Î¸¶ÄÏ¡¤Áß±¹ ÃÑ°ý ·¹¿Ë ¿Õ ¼ö¼®ºÎȸÀå, ¾Æ½ºÆ®¶óÁ¦³×Ä« ¾Æ½Ã¾ÆÁö¿ª ÃÑ°ý ½Çºñ¾Æ ¹Ù·¼¶ó »çÀå, ¾Æ½ºÆ®¶óÁ¦³×Ä« ÀÎÅͳ»¼Å³Î¸¶ÄÏ À繫ÃÑ°ý ¾ÈÄí½Ã ³­µå¶ó ºÎȸÀå, Çѱ¹¾Æ½ºÆ®¶óÁ¦³×Ä« ±è»óÇ¥ ´ëÇ¥ÀÌ»ç »çÀå.

SK Chemicals plans to supply products developed and produced to 12 global countries through AZ. SK Chemicals announced on the 19th that it has produced the first commercial product of a diabetes complex jointly developed with AstraZeneca.

SK Chemicals explained that it recently held an event to inspect and celebrate the global joint business of the two companies with the participation of SK Discovery Vice Chairman Choi Chang-won, SK Chemicals President Ahn Jae-Hyun, AZ Senior Vice Chairman Leon Wang, and Korea AstraZeneca President Kim Sang-pyo. SK Chemicals is one of the subsidiaries of SK Discovery. The event was prepared to check the progress of SK Chemicals and AstraZeneca's joint development of di

Kim, Jin-Gu(kjg@dailypharm.com)
If you want to see the full article, please JOIN US (click)